Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep
In a study scientists evaluate the effects of glucagon, GIP, and GLP- 1 receptors in one compound (i.e
Beyond their original design for diabetes and the notable side effect of losing significant amounts of weight, clinical trials have shown that GLP-1s reduce the risk of heart attacks, strokes, kidney disease progression, heart failure, and even COVID-19 mortality
This acute synergy is pharmacologically reasonable, but the longer-term body-composition, recovery and sleep benefits of this specific blend are not validated by controlled human trials read such claims as hypotheses (research suggests, may)
Suffering from symptoms related to vitamin B12 deficiency (more details below)